Despite all these findings, the heterogeneity of disease’s pathogenesis through metabolic pathways underlines the need for deeper investigation, especially genetic factors such as IGF-1 and their penetration in disease progression and liver fibrosis. Here, IGF1 is linked to Hepatic fibrosis.